Abstract

Neural progenitor cell expansion is critical for normal brain development and an appropriate response to injury. During the brain growth spurt, exposures to general anesthetics, which either block the N-methyl-d-aspartate receptor or enhance the γ-aminobutyric acid receptor type A can disturb neuronal transduction. This effect can be detrimental to brain development. Until now, the effects of anesthetic exposure on neural progenitor cell expansion in vivo had seldom been reported. Here, minimally invasive micro positron emission tomography (microPET) coupled with 3′-deoxy-3′ [18F] fluoro-l-thymidine ([18F]FLT) was utilized to assess the effects of sevoflurane exposure on neural progenitor cell proliferation. FLT, a thymidine analog, is taken up by proliferating cells and phosphorylated in the cytoplasm, leading to its intracellular trapping. Intracellular retention of [18F]FLT, thus, represents an observable in vivo marker of cell proliferation. Here, postnatal day 7 rats (n = 11/group) were exposed to 2.5% sevoflurane or room air for 9 h. For up to 2 weeks following the exposure, standard uptake values (SUVs) for [18F]-FLT in the hippocampal formation were significantly attenuated in the sevoflurane-exposed rats (p < 0.0001), suggesting decreased uptake and retention of [18F]FLT (decreased proliferation) in these regions. Four weeks following exposure, SUVs for [18F]FLT were comparable in the sevoflurane-exposed rats and in controls. Co-administration of 7-nitroindazole (30 mg/kg, n = 5), a selective inhibitor of neuronal nitric oxide synthase, significantly attenuated the SUVs for [18F]FLT in both the air-exposed (p = 0.00006) and sevoflurane-exposed rats (p = 0.0427) in the first week following the exposure. These findings suggested that microPET in couple with [18F]FLT as cell proliferation marker could be used as a non-invasive modality to monitor the sevoflurane-induced inhibition of neural progenitor cell proliferation in vivo.

Highlights

  • Animals exposed neonatally to general anesthetics develop cognitive deficits and behavioral abnormalities later in their lives [1,2,3]

  • The developing animals were examined with microPET scans in conjunction with [18F]FLT administration at 1, 2, and 4 weeks following the exposure

  • The significantly lower [18F]FLT uptake and retention in sevofluraneexposed rats could suggest that the cell proliferation in the hippocampal regions was inhibited in the first week following the 9-h sevoflurane exposure

Read more

Summary

Introduction

Animals exposed neonatally to general anesthetics develop cognitive deficits and behavioral abnormalities later in their lives [1,2,3]. In the developing CNS, the excitatory signal conferred by γ-aminobutyric acid and glutamate via synaptic transmission is neural trophic in nature to neurons growth and critical to orchestrate the neurons to form neuronal circuits [21,22,23]. The γ-aminobutyric acid type A receptors (GABAARs) and N methyl-d-aspartate receptors (NMDARs) are the primary receptors, which mediated the excitatory signal transmission. The common anesthetics are believed to act either as the agonist to GABAARs, or as the antagonist to NMDARs [24,25,26]. Sevoflurane [fluoromethyl 2,2,2-trifluoro-1(trifluoromethyl) ethyl ether], for example, a volatile anesthetic commonly used in anesthesia and sedations in pediatric patients, is considered to act as an agonist to the GABAARs at anesthesia relevant concentration [27]. Lengthy exposure of immature CNS to anesthetic agents that target on these receptors would conceivably affect the CNS development adversely

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call